Finnish VC investor Tesi and Swiss biopharmaceutical group Debiopharm have invested in a $10m series-B funding round for Basel-based genomic data management company BC Platforms.
GP and Katalist's founders are planning bolt-ons for the food and pharma supply chain software firm
Italian sports technology provider first sale attempt was hampered by the onset of COVID-19 in early 2020
Nick Chronias will lead the firm’s focus on private credit and private infrastructure secondaries
Dörte Höppner joined the GP in 2017 and will be responsible for its ESG initiatives globally